University of Oxford
- Country
- π¬π§United Kingdom
- Ownership
- Private
- Established
- 1096-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ox.ac.uk
Prevention of Mood Disorders by Folic Acid Supplementation
- Conditions
- DepressionBipolar Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2007-04-11
- Last Posted Date
- 2016-11-23
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 112
- Registration Number
- NCT00459264
- Locations
- π¬π§
University Department of Psychiatry, Oxford, Oxfordshire, United Kingdom
Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.
- Conditions
- Tuberculosis
- First Posted Date
- 2007-04-04
- Last Posted Date
- 2007-05-31
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 12
- Registration Number
- NCT00456183
- Locations
- π¬π§
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom
Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis
- Conditions
- HIV InfectionsTuberculous Meningitis
- Interventions
- First Posted Date
- 2007-02-12
- Last Posted Date
- 2008-08-07
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 253
- Registration Number
- NCT00433719
- Locations
- π»π³
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
π»π³Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG
- Conditions
- Tuberculosis
- First Posted Date
- 2007-01-29
- Last Posted Date
- 2007-01-29
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 16
- Registration Number
- NCT00427830
- Locations
- π¬π§
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, Oxfordshire, United Kingdom
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously
- Conditions
- Tuberculosis
- First Posted Date
- 2007-01-29
- Last Posted Date
- 2007-01-29
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 12
- Registration Number
- NCT00427453
- Locations
- π¬π§
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, Oxfordshire, United Kingdom
Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2008-08-07
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 66
- Registration Number
- NCT00423280
- Locations
- π¬π§
Department of Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom
A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers
- Conditions
- Tuberculosis
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2007-01-18
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 12
- Registration Number
- NCT00423839
- Locations
- π¬π²
MRC Labs, Fajara, Gambia
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.
- Conditions
- Tuberculosis
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2007-01-18
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 14
- Registration Number
- NCT00423566
- Locations
- π¬π§
University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom
Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen
- Conditions
- MalariaMalaria, Falciparum
- First Posted Date
- 2006-12-07
- Last Posted Date
- 2006-12-07
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 30
- Registration Number
- NCT00408668
- Locations
- π¬π§
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom
The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV
- Conditions
- TuberculosisHIV Infections
- First Posted Date
- 2006-11-03
- Last Posted Date
- 2011-03-28
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 20
- Registration Number
- NCT00395720
- Locations
- π¬π§
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom